Outcomes of patients with hematological malignancies who undergo unrelated donor hematopoietic stem cell transplantation with ATG-Fresenius versus ATG-Genzyme

To compare the outcomes of patients with hematological malignancies who received ATG-Fresenius (ATG-F) 20 mg/kg versus those who received ATG-Genzyme (ATG-G) 10 mg/kg in an unrelated donor hematopoietic stem cell transplantation (HSCT) procedure, a total of 186 patients who underwent their first all...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lu, Kong, Peiyan, Zhang, Cheng, Gao, Li, Zhu, Lidan, Liu, Jia, Gao, Shichun, Chen, Ting, Liu, Huanfeng, Yao, Han, Liu, Yuqing, Feng, Yimei, Zhao, Lu, Li, Yuxia, Gao, Lei, Zhang, Xi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182153/
https://www.ncbi.nlm.nih.gov/pubmed/37097455
http://dx.doi.org/10.1007/s00277-023-05220-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182153/
https://www.ncbi.nlm.nih.gov/pubmed/37097455
http://dx.doi.org/10.1007/s00277-023-05220-7

Ejemplares similares